ArticleBMC cancer2022

CSP I-plus modified rEndostatin inhibits hepatocellular carcinoma metastasis via down-regulation of VEGFA and integrinβ1.

Xueqin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.